Summary
Identification of islet autoantigens offers the possibility that antibody tests other than islet cell antibodies may be used for assessing risk of insulin-dependent diabetes mellitus (IDDM). The aim of this study was to determine the combination of islet autoantibody markers that could identify most future cases of IDDM. Islet cell antibodies, antibodies to glutamic acid decarboxylase (GAD)65, 37,000/ 40,000 Mr islet tryptic fragments, carboxypeptidase-H, and islet cell autoantigen (ICA)69 were measured in sera from 100 newly-diagnosed IDDM patients, 27 individuals prior to onset of IDDM, and 83 control subjects. Islet cell antibodies were detected in 88 % of IDDM patients and 81 % with pre-IDDM, GAD65 antibodies in 70 % of IDDM patients and 89 % with pre-IDDM, and antibodies to 37,000/40,000 Mr islet tryptic fragments in 54 % of IDDM patients and in 48 % with pre-IDDM. The latter were found only in conjunction with islet cell antibodies and were more frequent in young onset cases. All 20 IDDM patients and the 3 pre-IDDM subjects who had islet cell antibodies without GAD65 antibodies had antibodies to 37,000/40,000 Mr islet tryptic fragments, and all but one had disease onset before age 15 years. No sera strongly immunoprecipitated in vitro translated ICA69 or carboxypeptidase-H; 4 % of patients had anti-ICA69 and 11 % anti-carboxypeptidase-H levels above those of the control subjects. The findings suggest that none of the single antibody specificities are as sensitive as islet cell antibodies, but that a combination of GAD65 antibodies and antibodies to 37,000/40,000 Mr islet tryptic fragments has the potential to identify more than 90 % of future cases of IDDM. Such a strategy could eventually replace islet cell antibodies in population screening for IDDM risk assessment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CL:
-
Confidence limits
- CPH:
-
carboxypeptidase-H
- GAD:
-
glutamic acid decarboxylase
- GADA:
-
glutamic acid decarboxylase65 antibodies
- AA:
-
insulin autoantibodies
- ICA:
-
islet cell antibodies
- IDDM:
-
insulin-dependent diabetes mellitus
- JDF units:
-
Juvenile Foundation Diabetes units
References
Skyler JS, Marks JB (1993) Immune intervention in type 1 diabetes mellitus. Diabetes Rev 1: 15–42
Bonifacio E, Bingley PG, Shattock M et al. (1990) Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147–149
Riley WJ, Maclaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167–1172
Knip M, Vahasalo P, Karjalainen J, Lounamaa R, Akerblom HK, and the Childhood Diabetes in Finland Study group (1994) Natural history of preclinical IDDM in high risk siblings. Diabetologia 37: 388–393
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii: 1279–1283
Gleichmann H, Bottazzo GF (1987) Progress towards standardization of cytoplasmic islet cell antibody assays. Diabetes 36: 578–584
Bonifacio E, Lernmark A, Dawkins RL et al. (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106: 83–88
Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF (1990) Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33: 731–736
Greenbaum CJ, Palmer JP, Nagataki S et al. (1992) Improved specificity of ICA assays in the Fourth International Immunology of Diabetes serum exchange Workshop. Diabetes 41: 1570–1574
De Aizpurua HJ, Harrison LC, Cram DS (1992) An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41: 1182–1187
Thivolet CH, Tappaz M, Durand A et al. (1992) Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type I (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35: 570–576
Tuomilehto J, Zimmet P, Mackay IR et al. (1994) Antibodies to glutamic acid decarboxylase as predictiors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343: 1383–1385
Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes 43: 1304–1310
Genovese S, Bingley PJ, Bonifacio E et al. (1994) Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 344: 756
Grubin CE, Daniels T, Toivola B et al. (1994) A novel radiobinding assay to determine diagnostic accuracy of iso-form-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344–350
Petersen JS, Hejnaes KR, Moody A et al. (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: 459–467
Bosi E, Bonifacio E (1994) Autoantibodies in insulin-dependent diabetes mellitus. J Endocrinol Invest 17: 521–531
Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–795
Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS (1991) Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type 1 diabetes. J Clin Endocrinol Metab 73: 1197–1201
Pietropaolo M, Castano L, Babu S et al. (1993) Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92: 359–371
Homes E, Jacobsen KS, Gabrielsen OS, Kornses LS, Jansen EB, Eselund M (1991) Purification of mRNA and DNA binding proteins using magnetic beads. In: Kemshead JT (ed) Magnetic separation techniques applied to cellular and molecular biology. Wordsmith Conference Publications. Somerset, UK, pp 197–205
Wang AM, Doyle MV, Mark FF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717–9721
Saiki, RK, Gelfand DH, Stoffel S et al. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491
Lampasona V, Ferrari M, Bosi E, Pastore RM, Bingley PJ, Bonifacio E (1994) Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on Western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun 7: 665–674
Levi-Marchal C, Bridel M-P, Sodoyez-Goffaux F et al. (1991) Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type 1 diabetic children. Diabetes Care 14: 61–63
Genovese S, Bonifacio E, McNally JM et al. (1992) Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385–388
Gianani R, Pugliese A, Bonner-Weir S et al. (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41: 347–353
Timsit J, Caillat-Zucman S, Blondel H, Chédin P, Bach JF, Boitard C (1992) Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 792–795
Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK (1993) Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91: 350–356
Christie MR, Genovese S, Cassidy D et al. (1994) Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43: 1254–1259
Bingley PJ, Bonifacio E, Gale EAM (1993) Can we really predict IDDM? Diabetes 42: 213–220
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonifacio, E., Genovese, S., Braghi, S. et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38, 816–822 (1995). https://doi.org/10.1007/s001250050358
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050358